- The genetic and epigenetic abnormalities of plasma cfDNA as liquid biopsy biomarkers for diagnosis and prognosis stratification of pancreatic ductal adenocarcinomaWang, Y.; Jiang, R.; Xiao, S.; Shi, Y.; Zheng, J.; Li, Z.; Peng, J.; Sun, J.; Yang, G.; Yuan, J.; Lou, W.23rd ESMO World Congress on Gastrointestinal Cance, ELECTR NETWORK, 2021-06-30 To 2021.
- Non-invasive detection of pancreatic cancer by measuring DNA methylation of Basonuclin 1 and Septin 9 in plasmaLi, Xiao Bin; Ma, Jun; Liu, Zi Wen; He, Wen Fei; Li, Zong Ze; Cui, Ming; Hao, Huang; Zhou, Guang Peng; You, Lei; Wang, James; Han, Xiao Liang; Zhao, Yu Pei*Chinese Medical Journal, 2019, 132(12): 1504-1506.
- An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort StudyNakamura, Kota; Zhu, Zhongxu; Roy, Souvick; Jun, Eunsung; Han, Haiyong; Munoz, Ruben M.; Nishiwada, Satoshi; Sharma, Geeta; Cridebring, Derek; Zenhausern, Frederic; Kim, Seungchan; Roe, Denise J.; Darabi, Sourat; Han, In-Woong; Evans, Douglas B.; Yamada, Suguru; Demeure, Michael J.; Becerra, Carlos; Celinski, Scott A.; Borazanci, Erkut; Tsai, Susan; Kodera, Yasuhiro; Park, Joon Oh; Bolton, John S.; Wang, Xin*; Kim, Song Cheol; Von Hoff, Daniel*; Goel, Ajay*Gastroenterology, 2022, 163(5): 1252-+.被引 23
会议论文
An exosomal miRNA-based liquid biopsy signature for the noninvasive early detection of pancreatic ductal adenocarcinoma
10阅读
